AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
DEFERASIROX in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| JADAX 360 TABLET, COATED; ORAL | 2026/10.7/7354 | INNOVATA PHARMACEUTICALS | active | 12 Mar 2031 |
| JADAX 180 TABLET, COATED; ORAL | 2026/10.7/7353 | INNOVATA PHARMACEUTICALS | active | 12 Mar 2031 |
| JADAX 90 TABLET, COATED; ORAL | 2026/10.7/7352 | INNOVATA PHARMACEUTICALS | active | 12 Mar 2031 |
| DEFETOR 250 TABLET; ORAL | 2023/10.7/6426 | TORRENT PHARMACEUTICALS | active | 29 Jun 2028 |
| DEFETOR-500 TABLET; ORAL | 2023/10.7/6425 | TORRENT PHARMACEUTICALS | active | 29 Jun 2028 |
DEFERASIROX — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing DEFERASIROX, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track DEFERASIROX registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.